Skip to content

Norrköping Randomised Controlled Trial of Prostate Cancer Screening

Prostate screening for men aged 50-69 in Norrköping, Sweden: A twelve-year randomised controlled trial with twenty-year follow up

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN06342431
Enrollment
9000
Registered
2010-06-15
Start date
1987-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer Cancer Malignant neoplasm of prostate

Interventions

1494 men were randomly selected from a population of 9026 men aged 50-69 (the total male population of that age in the area). Information was issued through local media and an invitation to screening

Sponsors

Research Council of Southeast Sweden (Forskningsrådet i Sydöstra Sverige) (Sweden)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Men aged 50?69 years in 1987 residing in Norrköping, Sweden.

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Prostate Cancer mortality, determined by obtaining data from the Swedish Central Death Register on date and cause of death. Cause of death was also checked in the South-East Region Prostate Cancer Register.

Secondary

MeasureTime frame
1. Cost effectiveness, determined when twelve year survival data were accessible 2. Acceptance, assessed by questionnaires immediately after the screening examinations 3. Diagnostic accuracy Further information on the outcomes and methods of assessment may be found in the publications below.

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 29, 2026